About Vivo Capital
Vivo Capital is a company based in Palo Alto (United States). It operates as a B2B. Vivo Capital has completed 5 acquisitions, including Angiotech, Corza Medical and Dominique Dutscher.
- Headquarter Palo Alto, United States
-
Sectors
Financial Services
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Angiotech
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Vivo Capital
Unlock access to complete
Principal Team
2 people
Leadership Team
2 people
Partner Team
1 people
Venture Team
1 people
Trader Team
1 people
Unlock access to complete
Funding Insights of Vivo Capital
Detailed funding history for Vivo Capital
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vivo Capital
Vivo Capital has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Angiotech, Corza Medical and Dominique Dutscher.
Investment portfolio details for Vivo Capital
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of drug development, manufacturing and regulatory services
|
Locked | Locked | 2016 | Locked | |
|
Vaccines against various infectious diseases are developed by Sinovac.
|
Locked | Locked | 2001 | Locked | |
|
Angiotech is operated as a health and wellness blog.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Vivo Capital
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Vivo Capital
Detailed financials for Vivo Capital
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vivo Capital Comparisons
Peer comparison for Vivo Capital
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vivo Capital
Detailed competitors of Vivo Capital
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vivo Capital
Complete news archive for Vivo Capital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivo Capital
Vivo Capital is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Investments are directed toward the healthcare sector by Vivo Capital, a firm based in Palo Alto, United States. Venture capital and private equity strategies are employed to fund companies across various stages of development. Operations include sourcing and managing portfolios in biotechnology, pharmaceuticals, and medical devices. Geographic focus remains on opportunities within the U.S. and select international markets, with services encompassing equity financing and strategic advisory support.
Vivo Capital has made 5 acquisitions, including Angiotech, Corza Medical, and Dominique Dutscher.